As part of the agreement, Sanofi will provide Alloy with upfront license fees an...
With clinical trials facing multiple challenges, digital solutions could provide...
China's National Medical Products Administration has granted expanded approval t...
Newron and Myung In Pharm have signed a licence agreement for evenamide, for sch...
Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and...
Samsung Biologics has extended its collaboration with LigaChem Biosciences for a...
Financing was co-led by Forbion and General Atlantic, with participants includin...
The EC has approved the extension of Stallergenes Greer’s Palforzia for the trea...
Aspect Biosystems has secured $115m in a Series B financing round to advance the...
Orbis Medicines has raised €90m ($94m) in Series A funding to advance the develo...
Sickle cell patient advocacy groups in the US are calling for greater education ...
GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adul...
Acelyrin plans to initiate two Phase III studies this quarter, which will enrol ...
Variant has entered a multi-year research partnership with Novo Nordisk to ident...
Candid plans to conduct first-in-human studies in 2026 as it continues its T-cel...
